Candidate targets for hepatitis c virus-specific antiviral therapy

Intervirology

Volumn 40, Issue 5-6, 1997, Pages 378-393

  Bartenschlager, Ralf ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

HCV chemotherapy; HCV NS3 helicase; HCV NS5B polymerase; HCV proteinase inhibitors; HCV replication; HCV specific antivirals; Hepatitis C virus; NS3 4A proteinase complex of HCV

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR;

DRUG TARGETING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIFE CYCLE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; VIRUS ENVELOPE; VIRUS REPLICATION;

CYSTEINE ENDOPEPTIDASES; DNA HELICASES; ENDOPEPTIDASES; HEPACIVIRUS; HUMANS; MODELS, MOLECULAR; RNA REPLICASE; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 2642650337     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150570     Document Type: Article

References (122)

1. Houghton M: Hepatitis C viruses; in Fields BN, Knipe PM, Howlcy PM, et al (eds): Virology, Philadelphia, Lippincott-Raven Publishers, 1996. vol 2. pp 1035-1058.
2. Cuthbert JA: Hepatitis C: Progress and problems, Clin Microbiol Rev 1994;7:505-532.
3. Davis GL, Balart LA, Schil T ER, Lindsay K, Bodcnheimer HC Jr, Pcrrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JI, Van Thiel DH, Tantburro C, Lefkowitch J, Albcrth J, Mcschicvitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial, N Engl J Med 1989:321: 1501-1506.
4. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Cappcre H, Calcs P, Couzigou P, Benhamou JP: Recombinant human alpha-inlcrfcron in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France, Hepatology 1991;13:393-397.
5. Di Bisceglie AM, Shindo M, Fong TL, Fried MW, Swain MG, Gergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnaglc JH: A pilot study of ribavirin therapy for chronic hepatitis C, Hepatology 1992:16:649-654.
6. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y: A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitisC, Gastroenterology 1993; 105:507-512.
7. Reichard O, Yun ZB, Sonnerborg A, Weiland O: Hepatitis C viral RNA litres in scrum prior to, during, and after oral treatment with ribavirin for chronic hepatitisC, J Med Virol 1993: 41:99-102.
8. Koskinas J, Tibbs C, Saleh MG, Pereira LM, McFarlanc 1G, Williams R: Effects of ribavirin on intrahepatic and cxtrahcpatic expression of hepatitisC virus in interferon nonresponsive patients, J Med Virol 1995:45:29-34.
9. Lai M-Y, Kao J-H, Yang P-M, Wang J-T, Chen P-J, Chan K-W, Cltu J-S, Chen D-S: Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitisC, Gastroenterology 1996; 111:1307-1312.
10. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW: Hepatitis C virus: I'he major causative agent of viral non-A, non-B hepatitis, Br Med Bull 1990;46:423-441.
11. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science 1989: 244:359-362.
12. Inchauspc G, Yebedee S, Lee D-H, Sugitani M, Nasol T M, Prince A: Genomic structure of the human prototype strain H of hepatitisC virus: Comparison with American and Japanese isolates, Proc Natl Acad Sci USA 1991:88:10292-10296.
13. Kato N, I lijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K: Molecular cloning of the human hepatitisC virus genome from Japanese patients with non-A, non-B hepatitis, Proc Natl Acad Sci USA 1990;87:9524-9528.
14. Takamizawa A, Mori C, Fukc I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H: Structure and organization of the hepatitis C virus genome isolated from human carriers, J Virol 1991:65:1105-1113.
15. Okamolo H, Kojima M, Sakamoto M, lizuka H, Hadiwandowo S, Suwignyo S, Miyakawa Y, Mayumi M: The entire nucleotide sequence and classification of a hepatitis C virus isolate of novel genotype from an Indonesian patient with chronic liver disease, J Gen Virol 1994:75: 629-635.
16. Tsukiyama-Kohara K, lizuka N, Kohara M, Nomoto A: Internal ribosome entry site within hepatitisC virus RNA, J Virol 1992:66:1476-1483.
17. Wang C, Le S, Ali N, Siddiqui A: An RNA pseudoknot is an essential structural clement of the internal ribosome entry site located within the hepatitis C virus 5' noncoding region, RNA 1995;1:526-537.
18. Wang C, Sarnow P, Siddiqui A: Translation of human hepatitisC virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism, J Virol 1993:67:3338-3344.
19. Honda M, Ping L-H, Rijnbrand RC, Amphlctt E, Clarke B, Rowlands D, Lemon SM: Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitisC virus RNA, Virology 1996:222:31-42.
20. Tanaka T, Kato N, Cho M-J, Shimotohno K: A novel sequence found at the 3' terminus of hepatitis C virus genome, Biochem Biophys Res Comtnun 1995;215:744-749.
21. Kolvkhalov AA, Feinstonc SM, Rice CM: Identification of a highly conserved sequence element at the 3' terminus of hepatitisC virus genome RNA, J Virol 1996;70:3363-3371.
22. Tanaka T, Kato N, Cho M-J, Sugiyama K, Shi-motohno K: Structure of the 3' terminus of the hepatitisC virus genome, J Virol I996;70: 3307-3312.
23. Yamada N, Tanihara NK, Takada A, Yorihuzi T, Tsutsumi M, Shimomura H, Tsuji T, Date T: Genetic organization and diversity of the 3' noncoding region of the hepatitisC virus, Virology 1996:223:255-261.
24. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M: Gene mapping of the putative structural region of the hepatitisC virus genome by in vitro processing analysis, Proc Natl Acad Sci USA 1991:88:5547-5551.
25. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM: Expression and identification of hepatitisC virus polvprotein cleavage products, J Virol 1993:67:1385-1395.
26. Hijikala M, Mizushima H, Tanji Y, Komoda Y, Hirowatari Y, Akagi T, Kato N, Kimura K, Shimotohno K: Proteolytic processing and membrane association of putative nonstructur-al proteins of hepatitis C virus, Proc Natl Acad Sci USA 1993:90:10733-10777.
27. Selby MJ, Choo Q-L, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C, Houghton M: Expression, identification and subcellu-lar localization of the proteins encoded by the hepatitis C viral genome, J Gen Virol 1993:74: 1103-1113.
28. Tomci L, Failla C, Santolini E, De Francesco R, La Monica N: S3 is a serine protease required for processing of hepatitis C virus polyprotein, J Virol 1993:67:4017-4026.
29. Lin C, Lindenbach BD, Pragai BM, McOourt DW, Rice CM: Processing in the hepatitisC virus E2-NS2 region: Identification of p7 and twodistinct El-specific products with different C termini, J Virol 1994:68:5063-5073.
30. Mizushima H, Hijikata M, Asabe S-I, Hirota M, Kimura K, Shimotohno K: Two hepatitis C virus glycoprotein E2 products with different C termini, J Virol 1994;68:6215-6222.
31. Santolini E, Migliaccio G, La Monica N: Biosynthesis and biochemical properties of the hepatitis C virus core protein, J Virol 1994:68: 3661-3641.
32. Malsumoto M, Hwang SB, Jeng K-S, Zhu N, Lai MM: Homotypic interaction and multi-merization of hepatitis C virus core protein, Virology 1996:218:43-51.
33. Ralston R, Thudium K, Berger K, Kuo C, Gcr-vasc B, Hall J, Selby M, Kuo Ci, Houghton M, Choo Q-L: Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses, J Virol 1993; 67:6753-6761.
34. Spaete RR, Alexander D, Rugroden M, Choo Q-L, Berger K, Crawford K, Kuo C, Leng S, Lee C, Ralston R, Thudium K, Tung JW, Kuo G, Houghton M: Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells, Virology 1992:188:819-830.
35. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM: Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses, J Virol 1994;68:6147-6160.
36. Selby MJ, Glazer E, Masiarz F, Houghton M: Complex processing and protein:protein interactions in the E2:NS2 region of HCV, Virology 1994:204:114-122.
37. Grakoui A, McCourt DW, Wychowski C, Fein-stone SM, Rice CM: A second hepatitis C vi-rus-eneoded proteinase, Proc Natl Acad Sci USA 1993:90:10583-10587.
38. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K: Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus, J Virol 1993;67:4665-4675.
39. Hirowatari Y, Hijikata M, Tanji Y, Nyunoya H, Mizushima H, Kimura K, Tanaka T, Kato N, Shimotohno K: Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector, Arch Virol 1993; 133: 349-356.
40. Bartenschlager R, Ahlbom-Laakc L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis (' virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions, J Virol 1993:67:3835-3844.
41. Eckart MR, Selby M, Masiarz F, Lec C, Berger K, Crawford C, Kuo C, Kuo G, Houghton M, Choo Q-L: The hepatitis C virus encodes a serine proteinase involved in processing of the putative nonstructural proteins from the viral polyprotcin precursor, Biochem Biophvs Res Coram un 1993:192:399-406.
42. Grakoui A, McCourt DW, Wychowski C, Fcin-stone SM, Rice CM: Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polv-protein cleavage sites, J Virol 1993:67:2832-2843.
43. Manabe S, Fuke I, Tanishita O, Kaji C, Gonti Y, Yoshida S, Mori C, Takamizawa A, Yosida I, Okayama H: Production of nonstructural proteins of hepatitis C virus requires a putative viral protcasc encoded by NS3. Virology 1994: 198:636-644.
44. Suzich JA, Tantura JK, Palmer-Hill F, Warren-er P, Grakoui A, Rice CM, Feinstone SM, Collett MS: Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with related pestivirus and flavivirus enzymes, J Virol 1993:67:6152-6158.
45. Kim DW, Gwack Y, Han JH, Choc J:C-termi-nal domain of the hepatitis C virus NS3 protein contains an RNA helicase, Biochem Biophvs ResCommun 1995;215:160-166.
46. Gwack Y, Kim DW, Han JH, Choc J: Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein, Biochem Biophvs ResCommun 1996: 225:654-659.
47. Hong Z, Ferrari E, W'right-Minogue J, Chase R, Risano C, Seelig G, Lee C-G, Kwong AD: Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus antpli-con system, J Virol 1996:70:4261-4268.
48. Tai C-L, Chi W-K, Chen D-S, Hwang L-H: The helicase activity associated with hepatitis C virus nonstructural protein 3(NS3), J Virol 1996: 70:8477-8484.
49. Bartenschlager R, Ahlbom-Laakc L, Mous J, Jacobsen H: Kinetic and structural analyses of hepatitis C virus polyprotein processing, J Virol 1994;68:5045-5055.
50. Failla C, Tontei L, Dc Francesco R: Both NS3 and NS4A arc required for proteolytic processing of hepatitis C virus nonstructural proteins, J Virol 1994:68:3753-3760.
51. Lin C, Pragai BM, Grakoui A, Xu J, Rice CM: Hepatitis C virus NS3 serine proteinase: Trans-cleavage requirements and processing kinetics, J Virol 1994;68:8147-8157.
52. Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K: Hepatitis C virus-encoded non-slruetural protein NS4A has versatile functions in viral protein processing, J Virol 1995:69: 1575-1581.
53. Behrens S-E, Tomci L, Dc Francesco R: Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus, EMBO J 1996; 15: 12-22.
54. Lohmann V, Komer F, Herian U, Bartenschlager R: Biochemical properties of hepatitis C virus NS5B RNA-dcpcndcnt RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity, J Virol 1997;71:8416-8428.
55. Yuan ZH, Kumar U, Thomas HC, Wen YM, Monjardino J: Expression, purification, and partial characterization of HCV RNA polymerase, Biochem Biophvs ResCommun 1997; 232:231-235.
56. Rice CM, Lcnches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH: Nucleotide sequence of yellow lever virus: Implications for flavivirus gene expression and evolution, Science 1985: 229:726-733.
57. Meyers G, Thiel H-J: Molecular characterization of pcstiviruscs, Adv Virus Res 1996:47: 53-118.
58. Mucrhoff AS, Leary TP, Simons JN, Pilol-Malias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlaudcr GG, Desai SM, Mushawar IK: Genomic organization of GB viruses A and B: Two new members of the flaviviridae associated with GB agent hepatitis, J Virol 1995:69: 5621-5630.
59. Miller RH, Purcell RH: Hepatitis C virus shares amino acid sequence similarity with pes-tiviruses and flaviviruses as well as members of two plant virus subgroups, Proc Natl Acad Sci USA 1990:87:2057-2061.
60. Murphy FA, Fauquet CM, Bishop DHL, Gha-brial SA, Jarvis AW, Martelli GP, Mayo MA, Summers MD (eds): Classification and nomenclature of viruses, Sixth report of the international committee on taxonomy of viruses, Wien, Springer, 1995. pp 424-426.
61. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi F, Romagnani S, Gentilini P, Brechot C: Infection of peripheral mononuclear blood cells by hepatitis C virus, J Hepatol 1992:15:382-386.
62. Lumbrcras C, Delgado R, Fuertcs A, Loinaz C, Iglcsias J, Colina F, Aguado JM, Ginteno C, Garcia I, Lizasoain M, Moreno E, Noriega AR: Cl in ical signi ficancc of hepatitis C virus (HCV) infection in liver transplant recipients - role of serology and HCV RNA detection, Dig Dis Sci 1994:39:965-969.
63. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J, Gomez J: Dynamic behaviour of hepatitis C virus quasispecics in patients undergoing orthotopic liver transplantation, J Virol 1994:68:3425-3436.
64. Mizushima H, Hijikata M, Tanji Y, Kimura K, Shimotohno K: Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol 1994:68:2731-2734.
65. Lohmann V, Koch JO, Bartenschlagcr R: Processing pathways of the hepatitis C virus proteins, J Hepatol 1996:24(suppl 2): 11-19.
66. Hussy P, Langen H, Mous J, Jacobsen H: Hepatitis C virus core protein: Carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase, Virology 1996;224:93-104.
67. Santolini E, Pacini L, Fipaldini C, Migliaccio G, La Monica N: The NS2 protein of hepatitis C virus is a transmcmbranc polypeptide, J Virol 1995;69:7461-7471.
68. Strauss JH, Strauss EG: The alphaviruscs: Gene expression, replication, and evolution, Microbiol Rev 1994;58:491-562.
69. D’Souza ED, O’Sullivan E, Amphlett EM, Rowlands DJ, Sangar DV, Clarke BE: Analysis of NS3-mcdiated processing of the hepatitis C virus non-structural region in vitro, J Gen Virol 1994;75:3469-3476.
70. Tanji Y, Hijikata M, Hirowatari Y, Shimotoh-no K: Hepatitis C virus polyprotcin processing: Kinetics and mutagenic analysis of serine proteinase-dependent cleavage, J Virol 1994:68: 8418-8422.
71. Failla C, Tomei L, De Francesco R: An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A, J Virol 1995:69:1769-1777.
72. Tanji Y, Hijikata M, Hirowatari Y, Shimotoh-no K: Identification of the domain required from trans-cleavage activity of hepatitis C viral serine proteinase, Gene 1994:145:215-219.
73. Pizzi E, Tramontano A, Tomei L, La Monica N, Failla C, Sardana M, Wood T, De Francesco R: Molecular model of the specificity pocket of the hepatitis C virus protease: Implications for substrate recognition, Proc Natl Acad Sci USA 1994;91:888-892.
74. Berger A, Schcchler I: Mapping the active site of papain with the aid of peptide substrates and inhibitors, Phil Proc R Soc London B 1970: 257:249-264.
75. Kolykhalov AA, Agapov EV, Rice CM: Specificity of the hepatitis C virus NS3 prolcase: Effects of substitutions at the 3/4A, 4A/4B, 4B/ 5A, and 5A/5B cleavage sites on polyprotein processing, J Virol 1994:68:7525-7533.
76. Komoda Y, Hijikata M, Sato S, Asabe S-I, Kimura K, Shimotohno K: Substrate requirements of hepatitis C virus serine proteinase for intermolecular polvpeptide cleavage in Echeri-chiacoli, J Virol 1994;68:7351-7357.
77. Leinbach SS, Bhat RA, Xia S-M, Hum W-T, Stauffer B, Davis AR, Hung PP, Mizutani S: Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction, Virology 1994:204:163-169.
78. Bartenschlagcr R, Ahlborn-Laake L, Yasargil K, Mous J, Jacobsen H: Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase, J Virol 1995:69: 198-205.
79. Bartenschlagcr R, Lohmann V, Wilkinson T, Koch JO: Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation, J Virol 1995;69:7519-7528.
80. Lin C, Thomson J A, Rice CM: A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro, J Virol 1995:69:4273-4380.
81. Satoh S, Tanji Y, Hijikata M, Kimura K, Shimotohno K: The N-tcrminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A, J Virol 1995;69:4255-4260.
82. Koch JO, Lohmann V, Hcrian U, Bartenschla-ger R: In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor, Virology 1996:221:54-66.
83. Lin C, Rice CM: The hepatitis C virus NS3 serine proteinase and NS4A cofactor: Establishment of a cell-free trans-processing assay, Proc Natl Acad Sci USA 1995:92:7622-7626.
84. Butkicwicz NJ, Wcndcl M, Zhang R, Jubin R, Pichardo J, Smith EB, Han AM, Ingram R, Durkin J, Mui PW, Murray MG, Ramanathan L, Dasmahapatra B: Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: Identification of sequence and critical residues of NS4A cofactor activity, Virology 1996:225: 328-338.
85. Shimizu Y, Yamaji K, Masuho Y, Yokola T, Inouc H, Sudo K, Satoh S, Shimotohno K: Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 proteasc, J Virol 1996;70:127-132.
86. Tomei L, Failla C, Vitale RL, Bianchi E, De Francesco R: A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease, J Gen Virol 1996;77:1065-1070.
87. Steinkiihlcr C, Tomei L, De Francesco R: In vitro activity of hepatitis C virus protease NS3 purified from recombinant baculovirus-in-fected S19 cells, J Biol Client 1996:271:6367-6373.
88. Stcinkiihler C, Urbani A, Tomei L, Biasiol G, Sardana M, Bianchi E, Pcssi A, De Francesco R: Activity of purified hepatitis C virus protease NS3 on peptide substrates, J Virol 1996: 70:6694-6700.
89. Morgenstem KA, Landro JA, Hsiao K, Lin C, Gu Y, Su MS-S, Thomson JA: Polynucleotide modulation of the protease, nucleoside triphosphatase and helicasc activities of a hepatitis C virus NS3-4A complex isolated from transfected COS cells, J Virol 1997:71:3767-3775.
90. Love RA, Pargc HE, Wickcrsham JA, Hos-tomsky Z, Habuka N, Moomaw EW, Adachi T, Hostomska Z: The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site, Cell 1996;87:331-342.
91. Kim JL, Morgenstem KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Mark-land W, Lepre CA, O'Malley ET, Harbeson SL, Rice CM, Murcko MA, Caron PR, Thomson JA: Crystal structure of the hepatitis C virus NS3 protcase domain complexcd with a synthetic NS4A cofactor peptide, Cell 1996:87: 343-355.
92. l lahm B, Han DS, Back SI I, Song O-K, Clio M-J, Kim C-J, Shimotohno K, Jang SK: NS3-4A of hepatitis C virus is a chvmotrypsin-like protease, J Virol 1995:69:2534-2539.
93. Han DS, Hahm B, Tho H-M, Jang SL: Identification of the proteasc domain in NS3 of hepatitis C virus, J Gen Virol 1995:76:985-993.
94. De Francesco R, Urbani A, Nardi MC, Tomei L, Stcinkiihler C, Tramontano A: A zinc bind-ingsite in viral serine proteinases, Biochemistry 1996:35:13282-133287.
95. Stcmpniack M, Hostomska Z, Nodes B, Hos-tomsky Z: The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme, J Virol 1997;71:2881-2886.
96. Failla CM, Pizzi E, De Francesco R, Tramontano A: Redesigning the substrate specificity of the hepatitis C virus NS3 protease, Folding Design 1996:1:35-42.
97. Koch JO, Bartenschlager R: Determinants of substrate specificity in the NS3 serine-pro-teinase of the hepatitis C virus, Virology 1997;237:78-88.
98. Urbani A, Bianchi E, Narjes F, Tramontano A, De Francesco R, Stcinkiihler C, Pessi A: Substrate specificity of the hepatitis C virus serine prolease NS3. J Biol Chem 1997;272: 9204-9209.
99. Boulfard P, Bartenschlager R, Ahlborn-Laake L, Mous J, Roberts N, Jacobsen H: An in vitro assay for hepatitis C virus NS3 serine proteinase, Virology 1995:209:52-59.
100. Kakiuchi N, Hijikata M, Komoda Y, Tanji Y, Hirowatari Y, Shimotohno K: Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate, Biochem Biophys Res Commun 199S;210:1059-1065.
101. Overton O, McMillan D, Gillespie F, Mills J: Recombinant baculovirus-expresscd NS3 proteinase of hepatitis C virus shows activity in cell-based and in vitro assays, J Gen Virol 1995:76:3009-3019.
102. Shoji I, Suzuki T, Chieda S, Sato M, Harada T, Chiba T, Matsuura Y, Miyamura T: Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli Hepatology 1995:22:1648-1654.
103. Suzuki T, Sato M, Chieda S, Shoji I, Harada T, Yamakawa Y, Watabe S, Matsuura Y, Miyamura T: In vivo and in vitro trans-cleav-agc activity of hepatitis C virus serine proteinase expressed by recombinant baculovi-ruscs, J Gen Virol 1995;76:3021-3029.
104. Chu M, Mierzwa R, Truumees I, King A, Patel M, Berric R, Hart A, Butkicwicz N, Dasmahapatra B, Chan TM, Puar MS: Structure of SCH 68631: A new hepatitis C virus proteinase inhibitor from Slreplomyces sp, Tetrahedron Lett 1996:40:7229-7232.
105. Kadare G, Hacnni A-L: Virus-encoded RNA heiicases, J Virol 1997;71:2583-2590.
106. Walker JE, Sarastc M, Runswick MJ, Gay NJ: Distantly related sequences in the a- and b-subunits of ATP synthetase, myosin, kinases and other ATP-requiring enzymes and aconi-mon nucleotide binding fold, Embo J 1982:1: 945-951.
107. Preugschat F, Averett DR, Clarke BE, Porter DJT: A steady-state and pre-stcady-statc kinetic analysis of the NTPase activity associated with the hepatitisC virus NS3 hellicasc domain, J Biol Chcm 1996.271:24449-24457.
108. Kim DW, Gwack Y, Han JH, Choc J: Towards defining the minimal functional domain for NTPase and RNA hclicasc activities of the hepatitisC virus NS3 protein, Virus Res 1997;49:17-25.
109. Kanai A, Tanabe K, Kohara K: Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA hclicasc, FEBS Lett 1995:376: 221-224.
110. Yao N H, Hesson T, Cable M, Hong Z, Kwong AD, Le HV, Weber PC: Structure of the hepatitis C virus RNA helicase domain, Nat Struct Biol 1997:4:463-467.
111. Hwang SB, Park K-J, Kim Y-S, Sung YC, Lai MMC: HepatitisC virus NS5B protein is a membrane-associated phosphoprotcin with a predominantly perinuclear localization, Virology 1997;227:439-446.
112. Ncufcld KL, Richards OC, Ehrcnfcld E: Purification, characterization, and comparison of poliovirus RNA polymerase from native and recombinant sources, J Biol Chem 1991:266: 24212-24219.
113. Van Dyke TA, Rickies RJ, Flanegan JB: Gc-nome-length copies of poliovirion RNA are synthesized in vitro by the poliovirus RNA-dcpendent RNA polymerase, J Biol Chem 1982;257:4610-4617.
114. Oberste MS, Flanegan JB: Measurement of poliovirus RNA polymerase binding in poliovirion and nonviral RNA using a filter-binding assay, Nucl Acids Res 1988; 16:10339-10341.
115. Joyce CM, Steitz TA: Polymerase structures and function: Variations on a theme? J Bacteriology 1995;177:6321-6329.
116. Pocli O, Sauvagct I, Dclaruc M, Tordo N: Identification of four conserved motifs among the RNA-dependent polymerase encoding elements, Embo J 1989;8:3867-3874.
117. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA: Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase com-plcxcd with an inhibitor, Science 1992:256: 1783-1790.
118. Jacobo-Molino A, Ding J, Nanni RG, Clark AD Jr, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, Hizi A, Hughes SH, Arnold E: Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA, Proc Natl Acad Sci USA 1993;90:6320-6324.
119. Hirowatari Y, Hijikata M, Shimotohno K: A novel method for the analysis of viral proteinase activity encoded by hepatitis C virus in cultured cells, Anal Biochcm 1995:225:113-120.
120. Song O, Cho OH, Hahm B, Jang SK: Development of an in vivo assay system suitable for screening inhibitors of hepatitis C viral pro-tcasc, Mol Cells 1996:6:183-189.
121. Hahm B, Back SH, Lee TG, Wimmer E, Jang SK: Generation of a novel poliovirus with requirement of hepatitisC virus protease NS3 activity, Virology 1996:226:318-326.
122. Filocamo G, Pacini L, Migliaccio G: Chimeric Sindbis viruses dependent on the NS3 pro-tease of hepatitisC virus, J Virol 1997;71: 1417-1427.